These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22410247

  • 1. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H, Hinou H, Nishimura S.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2739-46. PubMed ID: 22410247
    [Abstract] [Full Text] [Related]

  • 2. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
    Hinou H, Miyoshi R, Takasu Y, Kai H, Kurogochi M, Arioka S, Gao XD, Miura N, Fujitani N, Omoto S, Yoshinaga T, Fujiwara T, Noshi T, Togame H, Takemoto H, Nishimura S.
    Chem Asian J; 2011 Apr 04; 6(4):1048-56. PubMed ID: 21305698
    [Abstract] [Full Text] [Related]

  • 3. Macrocyclic mechanism-based inhibitor for neuraminidases.
    Kai H, Hinou H, Naruchi K, Matsushita T, Nishimura S.
    Chemistry; 2013 Jan 21; 19(4):1364-72. PubMed ID: 23233350
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
    Hinou H, Kurogochi M, Shimizu H, Nishimura S.
    Biochemistry; 2005 Sep 06; 44(35):11669-75. PubMed ID: 16128567
    [Abstract] [Full Text] [Related]

  • 5. Multivalent S-sialoside protein conjugates block influenza hemagglutinin and neuraminidase.
    Yang Y, Liu HP, Yu Q, Yang MB, Wang DM, Jia TW, He HJ, He Y, Xiao HX, Iyer SS, Fan ZC, Meng X, Yu P.
    Carbohydr Res; 2016 Nov 29; 435():68-75. PubMed ID: 27710815
    [Abstract] [Full Text] [Related]

  • 6. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
    Carvalho ST, Sola-Penna M, Oliveira IA, Pita S, Gonçalves AS, Neves BC, Sousa FR, Freire-de-Lima L, Kurogochi M, Hinou H, Nishimura S, Mendonça-Previato L, Previato JO, Todeschini AR.
    Glycobiology; 2010 Aug 29; 20(8):1034-45. PubMed ID: 20466651
    [Abstract] [Full Text] [Related]

  • 7. Understanding viral neuraminidase inhibition by substituted difluorosialic acids.
    Weck S, Robinson K, Smith MR, Withers SG.
    Chem Commun (Camb); 2015 Feb 18; 51(14):2933-5. PubMed ID: 25587931
    [Abstract] [Full Text] [Related]

  • 8. The synthesis of a series of deoxygenated 2,3-difluoro-N-acteylneuraminic acid derivatives as potential sialidase inhibitors.
    Hader S, Watts AG.
    Carbohydr Res; 2013 Jun 07; 374():23-8. PubMed ID: 23618621
    [Abstract] [Full Text] [Related]

  • 9. Structural and functional-group tuning in the design of neuraminidase inhibitors.
    Sabesan S, Neira S, Wasserman Z.
    Carbohydr Res; 1995 Feb 17; 267(2):239-61. PubMed ID: 7895225
    [Abstract] [Full Text] [Related]

  • 10. 2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors.
    La Rocca P, Rota P, Piccoli M, Cirillo F, Ghiroldi A, Franco V, Allevi P, Anastasia L.
    Bioorg Med Chem; 2020 Jul 15; 28(14):115563. PubMed ID: 32616179
    [Abstract] [Full Text] [Related]

  • 11. Chemoenzymatic synthesis of sialosides containing C7-modified sialic acids and their application in sialidase substrate specificity studies.
    Khedri Z, Li Y, Muthana S, Muthana MM, Hsiao CW, Yu H, Chen X.
    Carbohydr Res; 2014 May 07; 389():100-11. PubMed ID: 24680514
    [Abstract] [Full Text] [Related]

  • 12. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
    Birikaki L, Pradeau S, Armand S, Priem B, Márquez-Domínguez L, Reyes-Leyva J, Santos-López G, Samain E, Driguez H, Fort S.
    Chemistry; 2015 Jul 20; 21(30):10903-12. PubMed ID: 26088695
    [Abstract] [Full Text] [Related]

  • 13. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
    Hirai G, Sodeoka M.
    Acc Chem Res; 2015 May 19; 48(5):1464-73. PubMed ID: 25894598
    [Abstract] [Full Text] [Related]

  • 14. Sialidase substrate specificity studies using chemoenzymatically synthesized sialosides containing C5-modified sialic acids.
    Cao H, Li Y, Lau K, Muthana S, Yu H, Cheng J, Chokhawala HA, Sugiarto G, Zhang L, Chen X.
    Org Biomol Chem; 2009 Dec 21; 7(24):5137-45. PubMed ID: 20024109
    [Abstract] [Full Text] [Related]

  • 15. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.
    Li J, Zheng M, Tang W, He PL, Zhu W, Li T, Zuo JP, Liu H, Jiang H.
    Bioorg Med Chem Lett; 2006 Oct 01; 16(19):5009-13. PubMed ID: 16876409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prenylated pterocarpans as bacterial neuraminidase inhibitors.
    Nguyen PH, Nguyen TN, Kang KW, Ndinteh DT, Mbafor JT, Kim YR, Oh WK.
    Bioorg Med Chem; 2010 May 01; 18(9):3335-44. PubMed ID: 20363636
    [Abstract] [Full Text] [Related]

  • 19. Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
    Slack TJ, Li W, Shi D, McArthur JB, Zhao G, Li Y, Xiao A, Khedri Z, Yu H, Liu Y, Chen X.
    Bioorg Med Chem; 2018 Nov 15; 26(21):5751-5757. PubMed ID: 30389408
    [Abstract] [Full Text] [Related]

  • 20. Biocatalysis versus Molecular Recognition in Sialoside-Selective Neuraminidase Biosensing.
    Alshanski I, Toraskar S, Shitrit A, Gordon-Levitan D, Jain P, Kikkeri R, Hurevich M, Yitzchaik S.
    ACS Chem Biol; 2023 Mar 17; 18(3):605-614. PubMed ID: 36792550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.